For Discovery & Sharing: Visit Vox World

For Support: +1 608-716-7539

Voximetry Introduces Professional Dosimetry Services for the Clinic, a Paradigm Shift in Nuclear Medicine.

The accuracy leader in advanced dosimetry technology now offers dosimetry as a remote service, making routine dosimetry for radiopharmaceutical therapy possible for more clinics.

Madison, WI – Voximetry, a pioneer in advanced dosimetry software, announces RPT Dosimetry Clinical Services, designed to maximize access to patient-specific dosimetry and empower clinicians to focus on what truly matters: delivering exceptional patient care.

Despite the acknowledged value in routine dosimetry for optimizing treatments and established reimbursement fee codes, many clinics have hesitated to embrace it. Until now, incorporating Radiopharmaceutical Therapy (RPT) dosimetry has required advanced, in-house software and a trained physics staff. With services from Voximetry, clinics now have the choice to integrate dosimetry into their workflows without waiting for capital budgets, training programs, or qualified staff.

“This is a paradigm shift that harkens back to the days of radiopharmaceutical compounding by in-house radiopharmacies. Once commercial distribution options became available, clinics quickly realized it would reduce costs and improve quality by outsourcing to businesses with economies of scale,” said Dr. Sue Wallace, CEO of Voximetry. “With remote dosimetry services, more clinicians can now include patient-specific dose assessments for tumors and critical organs in patient management.”

Voximetry’s dosimetry services are designed to provide simplicity you can trust. Centers need only upload one or more quantitative SPECT-CTs to a secure cloud repository, protecting confidential patient information. From there, Voximetry’s experts take over, using Torch® Dose Assessment, the most accurate software with the only full Monte Carlo dosimetry calculations, to provide comprehensive reports that are ready to support billing of existing reimbursement codes.

“We’ve worked hard to make this complex science as simple as upload, download, done,” said Gregg Daversa, VP of Professional Services Operations. “The whole point is to support clinicians with fast, safe, reliable dose assessments to help improve care and keep their mind on patients. “

The benefits for clinics choosing dosimetry as a service extend beyond financial and operational efficiency. By harnessing the power of cloud-based technology and specialized expertise, clinics are assured consistent quality and accuracy of dosimetry assessments. With reports generated in days, physicians receive timely insights into treatment efficacy and potential side effects, enabling them to make informed decisions quickly and with greater confidence. Perhaps most importantly, Voximetry’s dosimetry services empower clinics to fulfill their mission of providing compassionate and effective care to patients. Throughout the process, the physician remains the decision maker for each patient, integrating dosimetric information with clinical data to make personalized RPT a reality.

About Voximetry

Voximetry is committed to delivering uncompromised, personalized RPT through wide-ranging collaboration, deep scientific expertise, and technology-forward progress.   Based in Madison, Wisconsin, Voximetry is a Healthtech software and services company specializing in commercialization of complex algorithms on high-speed Graphic Processing Units (GPUs).    Currently focused on radiation transport science and voxel-level dosimetry, Voximetry is pioneering patient-specific radiopharmaceutical treatment planning (RPT) in advanced stage cancer patients.

About Torch

Torch® Dose Assessment software is a proprietary product developed by Voximetry and approved for clinical use by the FDA. Torch design and development continues to be supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R43CA221491 and 2R44CA291564. The product is solely the responsibility of Voximetry and does not represent the official views of the National Institutes of Health.

Torch design and development was supported by grants from the University of Wisconsin-System SBIR Advance Matching Grant Fund through its partnership with the Wisconsin Economic Development Corporation.